| About the Companion Website |
|
vi | |
| Contributors |
|
vii | |
| Foreword |
|
xvi | |
| Preface |
|
xvii | |
| Acknowledgments |
|
xviii | |
| Part I Principles and Techniques |
|
1 | (376) |
|
Section I Basic Knowledge |
|
|
3 | (56) |
|
1 Atherogenesis and Inflammation |
|
|
3 | (14) |
|
|
|
|
|
|
|
|
|
2 The Essentials of Femoral Vascular Access and Closure |
|
|
17 | (10) |
|
|
|
|
|
3 Radial Artery, Alternative Arm Access and Related Techniques |
|
|
27 | (7) |
|
|
|
|
|
|
|
|
|
4 Optimal Angiographic Views for Coronary Angioplasty |
|
|
34 | (10) |
|
|
|
|
|
|
|
44 | (15) |
|
|
|
|
|
|
|
Section II Imaging and Physiology |
|
|
59 | (79) |
|
6 Physiologic Assessment in the Cardiac Catheterization Laboratory: CFR, FFR, iFR and Beyond |
|
|
59 | (12) |
|
|
|
|
|
7 Intravascular Ultrasound and Virtual Histology: Principles, Image Interpretation and Clinical Applications |
|
|
71 | (20) |
|
|
|
|
|
|
|
8 Optical Coherence Tomography, Near-Infrared Spectroscopy and Near-Infrared Fluorescence Molecular Imaging |
|
|
91 | (16) |
|
|
|
|
|
|
|
|
|
|
|
9 Complementary Imaging Techniques: Multislice Computed Tomography of Coronary Arteries |
|
|
107 | (19) |
|
|
|
|
|
|
|
|
|
10 Cardiovascular Magnetic Resonance Imaging |
|
|
126 | (12) |
|
|
|
|
|
Section III PCI in Different Clinical Settings |
|
|
138 | (30) |
|
11 Stable Coronary Artery Disease |
|
|
138 | (10) |
|
|
|
|
|
12 PCI Strategies in Acute Coronary Syndromes without ST Segment Elevation (NSTEACS) |
|
|
148 | (7) |
|
Georgios E. Christakopoulos |
|
|
|
|
|
|
13 Primary and Rescue PCI in Acute Myocardial Infarction and Elements of Myocardial Conditioning |
|
|
155 | (8) |
|
|
|
|
|
|
|
14 The Management of Cardiogenic Shock and Hemodynamic Support Devices and Techniques |
|
|
163 | (5) |
|
|
|
|
|
|
|
Section IV PCI in Different Lesion Types |
|
|
168 | (56) |
|
15 Percutaneous Coronary Intervention in Unprotected Left Main |
|
|
168 | (7) |
|
|
|
|
|
|
|
16 Bifurcation Lesion Stenting |
|
|
175 | (10) |
|
|
|
|
|
|
|
|
|
17 Risk Stratification Approach to Multivessel Coronary Artery Disease |
|
|
185 | (5) |
|
|
|
|
|
18 Chronic Total Coronary Occlusion |
|
|
190 | (11) |
|
|
|
|
|
19 Percutaneous Coronary Intervention of Arterial and Vein Grafts |
|
|
201 | (4) |
|
|
|
|
|
|
|
20 Interventional Approach in Small Vessel, Diffuse and Tortuous Coronary Artery Disease |
|
|
205 | (8) |
|
|
|
21 In-Stent Restenosis in New Generation DES Era |
|
|
213 | (11) |
|
|
|
|
|
Section V Special Techniques and Complications |
|
|
224 | (72) |
|
22 Laser, Rotational and Orbital Coronary Atherectomy |
|
|
224 | (9) |
|
|
|
|
|
|
|
|
|
23 Thrombus-Containing Lesions |
|
|
233 | (11) |
|
|
|
|
|
24 Specialized Balloons in Percutaneous Coronary Intervention: Cutting, Scoring, Gliding and Drug-Eluting Balloons |
|
|
244 | (4) |
|
|
|
|
|
|
|
25 Coronary Artery Dissections, Perforations and the No-Reflow Phenomenon |
|
|
248 | (19) |
|
|
|
|
|
|
|
|
|
|
|
|
|
26 Access Site Complications |
|
|
267 | (7) |
|
|
|
|
|
|
|
27 Renal Insufficiency and the Impact of Contrast Agents |
|
|
274 | (8) |
|
|
|
|
|
28 Radiation Management in Interventional Cardiology |
|
|
282 | (8) |
|
|
|
|
|
29 Concepts of Cell Therapy and Myocardial Regeneration |
|
|
290 | (6) |
|
|
|
|
|
|
|
|
|
Section VI Clinical Trials in Coronary Heart Disease |
|
|
296 | (81) |
|
30 Statistical Essentials in the Design and Analysis of Clinical Trials |
|
|
296 | (5) |
|
|
|
|
|
31 Historical Perspective of Sirolimus and Paclitaxel-Eluting Stent Clinical Studies |
|
|
301 | (12) |
|
|
|
|
|
|
|
|
|
32 Cobalt-Chromium Everolimus-Eluting Stents |
|
|
313 | (13) |
|
|
|
|
|
|
|
|
|
|
|
33 Platinum-Chromium Everolimus-Eluting Stents |
|
|
326 | (9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
335 | (9) |
|
|
|
|
|
|
|
|
|
35 The Biolimus Stent Family |
|
|
344 | (16) |
|
|
|
|
|
|
|
36 The Biotronik Stent Family |
|
|
360 | (8) |
|
|
|
|
|
|
|
37 Novel Drug-Eluting Stent Systems |
|
|
368 | (11) |
|
|
|
|
|
|
| Part II Interventional Pharmacology |
|
377 | (108) |
|
Section I Fundamentals of Interventional Pharmacology |
|
|
379 | (18) |
|
38 Basics of Antiplatelet and Anticoagulant Therapy for Cardiovascular Disease |
|
|
379 | (10) |
|
|
|
|
|
39 Balance of Ischemia and Bleeding in Selecting Antithrombotic Regimens |
|
|
389 | (8) |
|
|
|
|
|
Section II Pharmacological Agents |
|
|
397 | (56) |
|
40 Oral Antiplatelet Agents in PCI |
|
|
397 | (11) |
|
|
|
|
|
|
|
|
|
41 Parenteral Anticoagulant Agents in PCI |
|
|
408 | (7) |
|
|
|
|
|
|
|
42 Parenteral Antiplatelet Agents in PCI |
|
|
415 | (6) |
|
|
|
|
|
|
|
43 Role of Parenteral Agents in PCI for Stable Patients |
|
|
421 | (11) |
|
|
|
|
|
|
|
44 Vasoactive and Antiarrhythmic Drugs During PCI |
|
|
432 | (4) |
|
|
|
|
|
45 The Optimal Duration of Dual Antiplatelet Therapy After PCI |
|
|
436 | (7) |
|
|
|
|
|
|
|
46 Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants After PCI |
|
|
443 | (10) |
|
|
|
|
|
|
|
|
|
Section III Pharmacological Testing |
|
|
453 | (32) |
|
47 Peri-procedural Platelet Function Testing in Risk Stratification and Clinical Decision Making |
|
|
453 | (6) |
|
|
|
|
|
|
|
|
|
48 Genetics and Pharmacogenetics in Interventional Cardiology |
|
|
459 | (10) |
|
|
|
|
|
|
|
49 Monitoring and Reversal of Anticoagulation and Antiplatelet Agents |
|
|
469 | (18) |
|
|
|
|
| Part III Hypertension and Structural Heart Disease |
|
485 | (156) |
|
Section I Systemic and Pulmonary Hypertension |
|
|
487 | (20) |
|
50 Right Heart Catheterization and Pulmonary Hemodynamics |
|
|
487 | (4) |
|
|
|
51 Treatment of Pulmonary Embolism: Medical, Surgical and Percutaneous |
|
|
491 | (8) |
|
|
|
|
|
52 Renal Denervation for Resistant Hypertension |
|
|
499 | (8) |
|
|
|
|
|
|
|
|
|
Section II Structural Heart Interventions |
|
|
507 | (39) |
|
53 Antithrombotic Strategies in Valvular and Structural Heart Disease Interventions |
|
|
507 | (10) |
|
|
|
|
|
|
|
54 Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy |
|
|
517 | (8) |
|
|
|
|
|
|
|
55 Left Atrial Appendage Exclusion |
|
|
525 | (5) |
|
|
|
|
|
56 Cryptogenic Stroke, Patent Foramen Ovale and ASD Closure |
|
|
530 | (10) |
|
|
|
57 Paravalvular Leak Closure and Ventricular Septal Defect Closure |
|
|
540 | (6) |
|
|
|
|
|
|
|
|
|
Section III Valvular Heart Disease Interventions |
|
|
546 | (95) |
|
58 Aortic Valvuloplasty and Large-Bore Percutaneous Arterial Access |
|
|
546 | (12) |
|
|
|
|
|
|
|
|
|
59 Transfemoral Aortic Valve Implantation: Preparation, Implantation and Complications |
|
|
558 | (11) |
|
|
|
|
|
|
|
|
|
|
|
60 Transthoracic Aortic Valve Implantation |
|
|
569 | (6) |
|
|
|
|
|
|
|
|
|
61 New Aortic Valve Technologies |
|
|
575 | (7) |
|
Dimytri Alexandre Siqueira |
|
|
|
|
|
|
582 | (10) |
|
|
|
|
|
|
|
|
|
|
|
63 Principles of Carpentier's Reconstructive Surgery in Degenerative Mitral Valve Disease |
|
|
592 | (7) |
|
|
|
|
|
64 Mitral Valve Repair: MitraClip and Emerging Techniques |
|
|
599 | (7) |
|
|
|
|
|
|
|
|
|
65 Balloon Mitral Valvuloplasty |
|
|
606 | (13) |
|
|
|
|
|
|
|
66 Pulmonary Artery and Valve Catheter-Based Interventions |
|
|
619 | (10) |
|
|
|
|
|
|
|
67 Imaging for Planning and Guidance for Structural Heart Interventions |
|
|
629 | (14) |
|
|
|
|
| Part IV Vascular Disease for the Interventionalist |
|
641 | (135) |
|
Section I Cerebrovascular Disease |
|
|
643 | (34) |
|
68 Acute Stroke Intervention |
|
|
643 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69 Carotid Artery Angioplasty and Stenting |
|
|
653 | (18) |
|
|
|
|
|
|
|
70 Cerebral Aneurysms: Diagnosis, Indications and Strategies for Endovascular Treatment |
|
|
671 | (6) |
|
|
|
Section II Aorta and Branch Diseases |
|
|
677 | (44) |
|
71 Management of Acute Aortic Syndromes |
|
|
677 | (10) |
|
|
|
|
|
72 Thoracic Endovascular Aortic Aneurysm Repair |
|
|
687 | (5) |
|
|
|
|
|
73 Endovascular Aortic Aneurysm Repair |
|
|
692 | (6) |
|
|
|
|
|
|
|
74 Acute and Chronic Mesenteric Ischemia |
|
|
698 | (7) |
|
|
|
|
|
|
|
75 Renal Artery Interventions |
|
|
705 | (8) |
|
|
|
|
|
|
|
|
|
76 Revascularization for Arteries in the Pelvis |
|
|
713 | (8) |
|
|
|
|
|
Section III Peripheral Arterial Disease |
|
|
721 | (33) |
|
|
|
721 | (5) |
|
|
|
|
|
78 Superficial Femoral Artery Interventions |
|
|
726 | (7) |
|
|
|
|
|
|
|
|
|
79 Popliteal Artery Interventions |
|
|
733 | (5) |
|
|
|
|
|
|
|
|
|
80 Below the Knee Interventions in Critical Limb Ischemia |
|
|
738 | (10) |
|
|
|
|
|
|
|
|
|
81 Subclavian, Vertebral and Upper Extremity Vascular Disease |
|
|
748 | (6) |
|
|
|
|
|
|
|
Section IV Venous Disease/Interventions |
|
|
754 | (22) |
|
82 Antithrombotic Strategies in Endovascular Interventions: Current Status and Future Directions |
|
|
754 | (5) |
|
|
|
83 Chronic Venous Insufficiency |
|
|
759 | (9) |
|
|
|
|
|
|
|
84 Cardiac Vein Anatomy and Transcoronary Sinus Catheter Interventions in Myocardial Ischemia |
|
|
768 | (8) |
|
|
|
|
|
|
| Index |
|
776 | |
Biežāk uzdotie jautājumi par e-grāmatām